For citations:
Muravyev YV, Lebedeva VV, Starkova AS, Rumyantseva DG, Urumova MM, Erdes S. The interchangeability of original tumor necrosis factor- α inhibitors and biosimilars in rheumatology: experience in replacing original infliximab with Flammagis for ankylosing spondylitis. Sovremennaya Revmatologiya=Modern Rheumatology Journal. 2020;14(2):104-109. (In Russ.) https://doi.org/10.14412/1996-7012-2020-2-104-109
Email this article 